RenovaCare Inc. is developing first-of-its-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. Its initial product under development targets the body’s largest organ, the skin. The company’s flagship technology, the CellMist™ System, uses its patented SkinGun™ to spray a liquid suspension of a patient’s stem cells – the CellMist™ Solution – onto wounds.

Company profile
Ticker
RCAR
Exchange
Website
CEO
Harmel S. Rayat
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
3M • Baxter International • Boston Scientific • Stryker • Becton, Dickinson And • Teleflex • Resmed • Haemonetics • Hill-Rom • Nuvasive ...
Former names
AMERICAN ALLIANCE CORP, ENTHEOS TECHNOLOGIES INC, Janus Resources, Inc., WHATSONLINE COM INC
SEC CIK
Corporate docs
IRS number
980170247
RCAR stock data
Calendar
12 Aug 22
16 Aug 22
31 Dec 22
Financial summary
Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 243.96K | 243.96K | 243.96K | 243.96K | 243.96K | 243.96K |
Cash burn (monthly) | 541.97K | 217.1K | 709.55K | 638.19K | 541.97K | 408.25K |
Cash used (since last report) | 851.2K | 340.98K | 1.11M | 1M | 851.2K | 641.19K |
Cash remaining | -607.25K | -97.02K | -870.45K | -758.37K | -607.25K | -397.23K |
Runway (months of cash) | -1.1 | -0.4 | -1.2 | -1.2 | -1.1 | -1.0 |
Institutional ownership, Q2 2021
0.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 10K |
Total shares | 5K |
Total puts | 0 |
Total calls | 0 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Captrust Financial Advisors | 5K | $10K |
Financial report summary
?Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
agreed, Arizona, Clark, Confidential, conspiracy, County, Cutler, decline, depreciation, disbursement, disposed, Dorr, dosposal, equipment, facility, Fire, funiture, Hale, Helen, inclusion, intangible, Judicial, leasehold, LLP, lodging, Medrano, National, Peter, Pickering, remain, remaining, renewed, Rigsby, satisfaction, Settlement, solvent, strain, Superior, temporarily, title, transaction, Union, Wilmer, WilmerHale
Removed:
expiring, measurement, slightly, space
Financial reports
Current reports
8-K
RenovaCare Announces Termination of StemCell Systems R&D Agreement
8 May 22
8-K
RenovaCare Announces Management Changes
24 Mar 22
8-K
RenovaCare Provides Clinical and Corporate Update
15 Mar 22
8-K
Entry into a Material Definitive Agreement
3 Feb 22
8-K
Other Events
10 Jan 22
8-K
Entry into a Material Definitive Agreement
30 Jul 21
8-K
Other Events
22 Jul 21
8-K
Regulation FD Disclosure
1 Jun 21
8-K
Departure of Directors or Certain Officers
13 Apr 21
8-K
RenovaCare Announces Organizational Changes and Appointment of New Officers
30 Mar 21
Registration and prospectus
424B4
Prospectus supplement with pricing info
25 Apr 18
POS AM
Prospectus update (post-effective amendment)
17 Apr 18
POS AM
Prospectus update (post-effective amendment)
19 Feb 18
S-1
IPO registration
11 Feb 18
POS AM
Prospectus update (post-effective amendment)
30 Oct 17
424B5
Prospectus supplement for primary offering
17 Oct 17
S-1/A
IPO registration (amended)
5 Jun 17
S-3/A
Shelf registration (amended)
11 May 17
Other
EFFECT
Notice of effectiveness
2 May 18
EFFECT
Notice of effectiveness
16 Apr 18
CORRESP
Correspondence with SEC
15 Apr 18
CORRESP
Correspondence with SEC
12 Apr 18
EFFECT
Notice of effectiveness
5 Mar 18
EFFECT
Notice of effectiveness
8 Nov 17
EFFECT
Notice of effectiveness
4 Jul 17
CORRESP
Correspondence with SEC
28 Jun 17
EFFECT
Notice of effectiveness
16 May 17
CORRESP
Correspondence with SEC
15 May 17
Ownership
4
RenovaCare / JOSEPH SIERCHIO ownership change
16 Mar 16
4
RenovaCare / Kenneth Kirkland ownership change
16 Mar 16
4
RenovaCare / Rhonda Beth Rosen ownership change
16 Mar 16
4
RenovaCare / Thomas Bold ownership change
16 Mar 16
4
RenovaCare / HARMEL S RAYAT ownership change
2 Feb 16
SC 13D
RenovaCare, Inc.
10 Jan 16
SC 13G
RenovaCare, Inc.
10 Jan 16
4
RenovaCare / HARMEL S RAYAT ownership change
4 Jan 16
4/A
RenovaCare / Thomas Bold ownership change
10 Jun 15
4
RenovaCare / Rhonda Beth Rosen ownership change
7 Jun 15